These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 18942885)

  • 21. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.
    Borges ÁH; O'Connor JL; Phillips AN; Neaton JD; Grund B; Neuhaus J; Vjecha MJ; Calmy A; Koelsch KK; Lundgren JD;
    J Infect Dis; 2016 Aug; 214(3):408-16. PubMed ID: 27132283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.
    Hamlyn E; Fidler S; Stöhr W; Cooper DA; Tambussi G; Schechter M; Miro JM; Mcclure M; Weber J; Babiker A; Porter K;
    AIDS; 2014 Mar; 28(6):869-74. PubMed ID: 24300544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
    Taylor BS; So-Armah K; Tate JP; Marconi VC; Koethe JR; Bedimo RJ; Butt AA; Gibert CL; Goetz MB; Rodriguez-Barradas MC; Womack JA; Gerschenson M; Lo Re V; Rimland D; Yin MT; Leaf D; Tracy RP; Justice AC; Freiberg MS
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):500-508. PubMed ID: 28696344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.
    Kumar P; DeJesus E; Huhn G; Sloan L; Small CB; Edelstein H; Felizarta F; Hao R; Ross L; Stancil B; Pappa K; Ha B;
    BMC Infect Dis; 2013 Jun; 13():269. PubMed ID: 23741991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with D-dimer levels in HIV-infected individuals.
    Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD; ; ;
    PLoS One; 2014; 9(3):e90978. PubMed ID: 24626096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    Kiefer EM; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Anastos K
    HIV Med; 2018 Nov; 19(10):734-744. PubMed ID: 30160347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.
    McDonald B; Moyo S; Gabaitiri L; Gaseitsiwe S; Bussmann H; Koethe JR; Musonda R; Makhema J; Novitsky V; Marlink RG; Wester CW; Essex M
    AIDS Res Hum Retroviruses; 2013 Jul; 29(7):993-9. PubMed ID: 23590237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein particle subclasses, cardiovascular disease and HIV infection.
    Duprez DA; Kuller LH; Tracy R; Otvos J; Cooper DA; Hoy J; Neuhaus J; Paton NI; Friis-Moller N; Lampe F; Liappis AP; Neaton JD;
    Atherosclerosis; 2009 Dec; 207(2):524-9. PubMed ID: 19515371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda.
    Siedner MJ; Bwana MB; Asiimwe S; Musinguzi N; Castillo-Mancilla J; Amanyire G; Tracy RP; Bangsberg DR; Orrell C; Haberer JE;
    AIDS; 2019 Nov; 33(13):2043-2048. PubMed ID: 31274541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
    Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Pearce WH; Greenland P; Green D; Tan J; Garside DB; Guralnik J; Ridker PM; Rifai N; McDermott MM
    Ann Intern Med; 2008 Jan; 148(2):85-93. PubMed ID: 18195333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease.
    Borges ÁH; Weitz JI; Collins G; Baker JV; Lévy Y; Davey RT; Phillips AN; Neaton JD; Lundgren JD; Deeks SG;
    AIDS; 2014 Jul; 28(12):1791-6. PubMed ID: 25003720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
    Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
    PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early changes in coagulation but not inflammatory biomarkers under intermittent ART: the randomized ANRS 106 WINDOW trial.
    Gallien S; Charreau I; Fonsart J; Mourah S; Kalidi I; Delobel P; Marchou B; Aboulker JP; Molina JM
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19551. PubMed ID: 25394058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
    Ghazi L; Baker JV; Sharma S; Jain MK; Palfreeman A; Necsoi C; Murray DD; Neaton JD; Drawz PE
    Am J Hypertens; 2020 Jan; 33(1):43-52. PubMed ID: 31800000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
    Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
    J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    Elvstam O; Medstrand P; Jansson M; Isberg PE; Gisslén M; Björkman P
    HIV Med; 2019 Oct; 20(9):571-580. PubMed ID: 31148335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.
    Affi R; Gabillard D; Dunyach-Remy C; Ntakpe JB; Moh R; Badje A; Kouame GM; Karcher S; Le Carrou J; Danel C; Chevalier MF; Rouzioux C; Eholie SP; Lavigne JP; Inwoley A; Anglaret X; Weiss L
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):138-145. PubMed ID: 33074857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?
    Justice AC; Freiberg MS; Tracy R; Kuller L; Tate JP; Goetz MB; Fiellin DA; Vanasse GJ; Butt AA; Rodriguez-Barradas MC; Gibert C; Oursler KA; Deeks SG; Bryant K;
    Clin Infect Dis; 2012 Apr; 54(7):984-94. PubMed ID: 22337823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmatic Coagulation Capacity Correlates With Inflammation and Abacavir Use During Chronic HIV Infection.
    van der Heijden WA; Wan J; Van de Wijer L; Jaeger M; Netea MG; van der Ven AJ; de Groot PG; Roest M; de Mast Q
    J Acquir Immune Defic Syndr; 2021 May; 87(1):711-719. PubMed ID: 33492017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals.
    Young LC; Roediger MP; Grandits G; Baker J; Somboonwit C; Williams I; Lundgren JD; Neaton JD; Soliman EZ
    Biomark Med; 2014; 8(9):1073-83. PubMed ID: 25402578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.